Variant NM_000492.4:c.1682C>A
| Name | NM_000492.4:c.1682C>A |
| Protein name | NP_000483.3:p.(Ala561Glu) |
| Genomic name (hg19) | chr7:g.117230409C>A UCSC |
| Genomic name (hg38) | chr7:g.117590355C>A UCSC |
| #Exon/intron | exon 13 |
| Legacy Name | A561E |
| Class | disease-causing |
| Subclass | CF-causing |
| WT sequence | TTTAATTTCCATTTTCTTTTTAGAG C AGTATACAAAGATGCTGATTTGTAT |
| Mutant sequence | TTTAATTTCCATTTTCTTTTTAGAG A AGTATACAAAGATGCTGATTTGTAT |
![]() |
![]() | dbSNP rs121909047 |
![]() | ![]() |
| Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
| VNZ-TEZ-DIVA | yes | no | yes | no |
clinical and functional data presented above are provided by Vertex
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 1 |
|---|---|
| CF | 1 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CF | 2678 | heterozygote | CF-causing- Undef |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|